Pfenex

YTD

ALL

Why Robinhood?

You can watch Pfenex and buy or sell other stocks, ETFs, and their options commission-free!

About PFNX

Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX.

CEO

Evert B. Schimmelpennink

CEOEvert B. Schimmelpennink

Employees

—

Employees—

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2009

Founded2009

Employees

—

Employees—

PFNX Key Statistics

Market cap

437.28M

Market cap437.28M

Price-Earnings ratio

-54.21

Price-Earnings ratio-54.21

Dividend yield

—

Dividend yield—

Average volume

1.62M

Average volume1.62M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$14.00

52 Week high$14.00

52 Week low

$5.26

52 Week low$5.26

People also own

Based on the portfolios of people who own PFNX. This list is generated using Robinhood data, and it’s not a recommendation.